HIT TYPE1 TYPE2 Common occurrence Initial 4 days 5 to 14days of Heparin therapy Thrombocytopenia < 30% >50% Immune mediated No Yes Complications None Thromboembolism Therapy Self limiting Needs alternative anticoagulation

Table 2: Clinical probability of HIT in a suspected patient evaluated by 4 ‘T’ score.